CLINICAL TRIALS PROFILE FOR ALTRETAMINE
✉ Email this page to a colleague
All Clinical Trials for ALTRETAMINE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00002936 ↗ | Altretamine and Etoposide in Treating Patients With HIV-Related Cancer | Completed | National Cancer Institute (NCI) | Phase 1 | 1996-07-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of altretamine plus etoposide in treating patients with HIV-related cancer. |
NCT00002936 ↗ | Altretamine and Etoposide in Treating Patients With HIV-Related Cancer | Completed | Roswell Park Cancer Institute | Phase 1 | 1996-07-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of altretamine plus etoposide in treating patients with HIV-related cancer. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ALTRETAMINE
Condition Name
Clinical Trial Locations for ALTRETAMINE
Trials by Country
Clinical Trial Progress for ALTRETAMINE
Clinical Trial Phase
Clinical Trial Sponsors for ALTRETAMINE
Sponsor Name